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Objective: To monitor the current duration of the application rates in vector programme
and the level of Aedes albopictus larvae susceptibility from three selected areas in
northeast district of Penang on two selected larvicides, temephos and Bacillus thur-
ingiensis subsp. israelensis (Bti) which are commonly used by Penang Health Depart-
ment for vector control.
Methods: The mosquito larvae were tested against two types of larvicides: (1) temephos
(Abate®) with diagnostic dosage (0.012 mg/L) and operational dosage (1 mg/L) and (2)
Bacillus thuringiensis subsp. israelensis (VectoBac® WG) with operational dosage
ranging from 6000 international toxic units per L to 24000 international toxic unit per L.
A total of 20 late third and early forth instar larvae were selected and transferred into
paper cup sized 300 mL using wide-mouthed pipette. The larvae were distributed into
each 300 mL paper cup containing 50 mL of aged tap water. The experiment was
replicated ﬁve times for each concentration tested. Each test was repeated three times. The
mortality was recorded after 24 h of exposure and recorded lethal time was based on 2 h
for temephos and 6 h for Bti. The control consisted of ethanol for temephos and only
seasoned water for Bti.
Results: The result showed that Aedes albopictus from Flat Hamna, Kampung Sungai
Gelugor and Kampung Tanjung Tokong were still susceptible to Bti and temephos.
However, higher lethal time and resistance ratio were detected in strain from Flat Hamna
which was a known dengue hot spot area in northeast of Penang.
Conclusions: The application of temephos and Bti in vector control activity in these
selected localities is still relevant in the control of Aedes larvae populations.1. Introduction
Insecticide is a toxic product and used to kill pest insects or
eliminate diseases carrying pests. Natural insecticide can also be
derived from natural plants [1]. An insecticide has to be applied inthe living place or habitat of the target insect to ensure that the
insecticide is touched or digested by the pest insects. Most of
the insecticides are nerve poison and kill the insect by
attacking the speciﬁc part in the metabolism mechanism inside
the insect's body [2]. However, the excessive use of the
insecticide brings several problems to the environment. The
most problematic case is the environmental contamination
through basic food chain, which endangers the insect, wildlife,
and human being. Many insects or animals are at risk as they
rely upon the main source of food contaminated with
insecticides.
Globally, temephos is the most widely used as it is easy to
handle, cheap in price, has good residual effect, has low toxicity
to mammalian and safe to apply to drinking water [3–5].ticle under the CC BY-NC-ND license (http://
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produced commercially to control Aedes mosquito larvae as a
larvicide used [6]. Larvicidal activity is very important in vector
control management because the effectiveness in polluted
water, has a long residual activity and can be used on any
stage of larva. Since 1970, it has been used against mosquito
larvae in stagnant water and in the vector management of
dengue fever, malaria and ﬁlariasis especially in Thailand [7]
and Malaysia since 1973 [8]. The larval control still primarily
utilised the temephos, despite the known existence of temephos
resistant populations in many parts of the world [9].
Bacillus thuringiensis subsp. israelensis (Bti) is a biological
larvicide and widely used to control mosquitoes and black ﬂies
[10,11]. Bti showed a fast killing effect with a good toxicology
proﬁle with the absence of cross-resistance with conventionally
used pesticides [12]. Product with Bti causes no harm and is safe
to the bird, man, ﬁsh and mammals [13,14]. The mode of action of
endotoxin to kill larvae is still unclear but the sequence of toxin
activation is well studied [15]. Once the bacteria are ingested, the
crystal will be dissolved in the naturally alkaline pH in the larval
midgut and the endotoxin attached were activated. The larvae
usually die within 2 or 3 days [16].
One of the major problems in vector control is development
of resistance to existing insecticides in the vectors. Recently,
resistance to temephos has been previously reported in Malaysia
and other country [17–19]. The widespread use of insecticide has
led to insecticide resistance in mosquitoes and become another
problem for the ability to control disease. Thus, Bti is an
alternative candidate to manage the resistance to temephos [4].
It contains four different larvicidal proteins, each acting in
different ways to make it difﬁcult to develop resistance [20].
Furthermore, there is no consistent resistance which has been
detected after a long-term treatment with Bti [21], but only a
moderate Bti resistance was reported locally [22].
Laboratory bioassay can only detect resistance when it pre-
sents in high frequencies in vector population. The early
detection of the resistance can improve the vector efﬁcacy by
improving the implementation of alternative control strategies.
Diagnostic dosage was used to determine insecticide resistance
against Anopheles, Culex quinquefasciatus and Aedes aegypti
(Ae. aegypti) [23]. It is a standard test for detecting and
measuring resistance, which should be available to the
researcher committees to make a comparison between other
countries in order to verify the standard dosage for all
insecticides. The baseline of diagnostic dose is possible to be
changed due to the current resistance status data. The
mortality assay based on time is one of the convenient
procedures which is easy, time-saving and feasible to deter-
mine insect susceptibility in the ﬁeld population [24].
Therefore, the purpose of this study is to monitor the current
duration of the application rates in vector programme and the
level of Aedes albopictus (Ae. albopictus) larvae susceptibility
from three selected areas in northeast district of Penang on two
selected larvicides, temephos and Bti which are commonly used
by Penang Health Department for vector control.
2. Materials and methods
2.1. Tested mosquitoes
The wild strain of Ae. albopictus mosquitoes from the three
selected areas with the highest reported dengue fever cases innortheast district of Penang were collected from the majority
(> 90%) of natural breeding sites such as tyres, discarded tins,
cans and ﬂower pots. Collections were carried out from three
selected areas on Penang Island: Flat Hamna (FH) Sungai Dua,
Kampung Sungai Gelugor (KSG) and Kampung Tanjung
Tokong (KTT) based on the methodologies described previously
[25]. Collected samples of Aedes larvae were brought back to the
laboratory, identiﬁed and were used in the bioassay test. Ae.
albopictus VCRU strain (susceptible strain), which served as
control reference baseline was obtained from insectarium of
Vector Control Research Unit, Universiti Sains Malaysia
(5210 N, 100180 E). This susceptible strain was colonised
since 1980s for more than 800 generations.
2.2. Temephos bioassay
Larvicide testing was prepared according to the World Health
Organization (WHO) procedure with a modiﬁcation on the
applied dose of commercial Abate® 1.1G [1.1% w/w, registered
by BASF (Malaysia) Sdn. Bhd] [8]. The mosquito larvae were
tested against two different dosages of temephos: (1)
recommended dose at 0.012 mg/L and (2) operational dose
that has been used by Department Health of Penang at 1 mg/L
and prepared with ethanol as solvent. A total of 20 late third
and early fourth instar larvae were selected and transferred
into paper cup sized 300 mL using wide-mouthed pipette.
Larvae were left for 1 h prior to the experiment to permit
acclimatization and no additional food was offered. After that
period, any abnormal larvae were replaced with healthy ones.
The larvae were distributed into each 300 mL paper cup con-
taining 50 mL of aged tap water. The experiment was replicated
ﬁve times for each concentration tested. Each test was repeated
three times.
The test solution was prepared by adding appropriate amount
of temephos in solvent and stirred for 30 s with a glass rod.
Fifteen minutes after solution has been prepared (to allow the
agent to mix well in the solvent), the mosquito larvae were
introduced into each cup and water was further added to make
up the ﬁnal volume of 200 mL. The control (untreated) consisted
of 1 mL of ethanol for temephos. Larval bioassay tests were run
under laboratory condition at temperature of (26 ± 2) C and
(60 ± 20)% relative humidity. Cumulative larval mortality was
recorded for 2 h with interval of 5 min for operational dosage of
temephos (1 mg/L). Larval mortality after 24 h was also recor-
ded after the exposure to temephos. The mortality of Ae. albo-
pictus was recorded after 24 h of exposure and was presented as
percentage, whereas, lethal time (LT) was based on 2 h. Lethal
data were log-transformed prior to statistical analysis to fulﬁl the
assumption of probit analysis [26]. The resistance ratio (RR) was
calculated by dividing the LT of the ﬁeld strain by the LT of the
susceptible strain.
RR of LT50 =
LT50 of field strain
LT50 of laboratory strain
2.3. Bti bioassays
VectoBac® WG was a commercial biolarvicidal formulation
of Bti with a potency of formulation 3000 international toxic
unit (ITU)/mg against Ae. aegypti. The larval bioassay tests were
conducted with slight modiﬁcations as previously described [27–
Table 2
Larval mortality of Ae. albopictus strains to different doses of VectoBac®
WG (Bti) after 24 h of continuous exposure.
Strains 24 h Post-exposure mortality (%)
6000 ITU/L 15000 ITU/L 24000 ITU/L
VCRU laboratory strain 100 100 100
FH 100 100 100
KSG 100 100 100
KTT 100 100 100
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1000 L (equivalent to 6000 ITU/L–24000 ITU/L). The
operational dose used for Bti application for control program
in Penang was based on the recommended dose by the
manufacturer as mentioned on the label. Three concentrations
were used in this study, which were 6000, 15000 and
24000 ITU/L with water as the solvent. The test of Bti was
assessed for 10 min–6 h after Bti applications and 24 h after
exposure to all of the concentrations tested. For each bioassay,
20 larvae per cup were exposed to different concentrations of
Bti. The appropriate dilution from stock solution was added to
the water in the cups to obtain the desired target doses. Five
cups per concentration (100 larvae) were performed for each
concentration tested. Each bioassay was repeated three times
and a control group was tested using water. The mean LT and
the RR were obtained for each sample, as described above.
3. Results
3.1. Toxicity of insecticide in 24 h
The study was performed based on three strains of Ae.
albopictus colonies collected from different localities and
VCRU susceptible strain was used as a reference strain. The
susceptibility tests of temephos were based on the number of Ae.
albopictus mortality for FH, KSG and KTT strain. All of the
strains showed 100% mortality on 0.012 mg/L (WHO diagnostic
dose) and 1 mg/L (operational dose for Health Department of
Penang) dosages (Table 1). Recommended dose for temephos
proposed by WHO (0.012 mg/L) and Health Department of
Penang (1 mg/L) which was 83.3% higher than WHO dose, gave
the same result of 100% mortality after 24 h post-treatment. Test
on Bti also showed 100% mortality against 6000, 15000 and
24000 ITU/L after 24 h post-exposure for all strains tested
(Table 2). This indicated that the Bti dosage recommended by
manufacturer was still effective against Ae. albopictus larvae for
all strains.
3.2. Temephos
The result showed the VCRU susceptible strain had the
lowest LT values compared to other ﬁeld strains (FH, KSG and
KTT). The LT50 values against Ae. albopictus from VCRU, FH,
KSG and KTT ranged from 36.44 min to 68.31 min. Wild
strains required longer time to be killed compared to the labo-
ratory strain (36.44 min). The LT50 of the operational dose
against Ae. albopictus from VCRU, FH, KSG and KTT were
36.44, 68.31, 64.86 and 50.61 min respectively. All of the LT50
values were higher for the ﬁeld strains (Table 1).
The results obtained from bioassay test revealed that FH
strains had signiﬁcantly longer LT when tested with operationalTable 1
Larval susceptibility of Ae. albopictus strains after 24 h of continuous expos
Strains % Mortality after 24 h LT50
0.012 mg/L 1 mg/L
VCRU laboratory strain 100 100 36.44
FH 100 100 68.31
KSG 100 100 64.86
KTT 100 100 50.61
a,b: The LT required to kill 50%/95% of larvae using 1 mg/L of temephos.dosage (1 mg/L) compared to VCRU and KTT strain (non-
overlapping of 50% and 95% CLs, P < 0.01; Table 1). However,
the values of LT50 for FH strain showed no statistical difference
compared to KSG strain (overlapping of 50% and 95% CLs,
P < 0.01; Table 1). Our result indicated that low mortality was
recorded within the ﬁrst 2 h after treatment with 0.012 mg/L
temephos dose in all of ﬁeld strains due to the lower concen-
tration compared to operational dose for Health Department of
Penang (1 mg/L).
3.3. VectoBac® WG susceptibility
The results obtained from Bti bioassay revealed that FH
strains had signiﬁcantly longer LT in all three dosages tested
compared to other strains (non-overlapping of 50% and 95%
CLs, P < 0.01; Table 3), which indicated that FH strain was less
tolerant to Bti. The result showed the VCRU susceptible strain
had the lowest LT values compared to other three ﬁeld strains
(FH, KSG and KTT). The LT50 of the 6000 ITU/L against Ae.
albopictus for VCRU, FH, KSG and KTT were 52.70, 107.06,
88.56 and 59.81 min respectively followed by 15000 ITU/L
(26.09, 63.92, 46.10, 32.94 min) and 24000 ITU/L (20.65,
40.90, 34.87, 27.96 min). All the LT50 values were higher for
the ﬁeld strains and the LT reduced with the increasing dose of
Bti. However, the LT values between each strain showed sig-
niﬁcant differences between tested doses (F = 1692.59, df = 2,
P = 0.00). Generally, the susceptibility decreased in order of
VCRU strain > KTT > KSG > FH.
3.4. Resistance of mosquito to temephos and Bti
All mosquitoes found to be still susceptible against temephos
at operational dosage (1 mg/L) (Table 1). Ae. albopictus from
FH showed the highest value of RR50 with 1.87 folds followed
by KSG and KTT with 1.77 and 1.39 respectively. The level of
susceptibility of Ae. albopictus larvae strains from FH, KSG and
KTT was generally considered susceptible to Bti (Table 3). At
6000 ITU/L Bti (VectoBac® WG), FH strain had the highest
value of RR at 2.03 followed with KSG and KTT at RR 1.68 andure to temephos.
(95% CL)a LT95 (95% CL)
b RR50 RR95
(31.69–40.03) 56.50 (48.46–89.89) – –
(65.78–70.99) 89.72 (83.99–99.70) 1.87 1.59
(62.36–67.47) 91.66 (85.29–108.68) 1.77 1.62
(42.04–56.39) 65.43 (57.97–180.57) 1.39 1.15
CL: Conﬁdence limit.
Table 3
LT and RR of Ae. albopictus from different localities to VectoBac® WG (Bti).
Dose (ITU/L) Locality LT50 (95% CL) RR LT95 (95% CL) RR
6000 FH 107.06 (101.31–112.18) 2.03 168.20 (155.78–188.05) 1.78
KSG 88.56 (86.24–90.78) 1.68 199.10 (189.62–210.50) 2.10
KTT 59.81 (52.20–67.15) 1.13 101.96 (85.23–156.64) 1.08
VCRU 52.70 (48.17–56.90) 1.00 94.68 (83.02–117.89) 1.00
15000 FH 63.92 (57.96–71.05) 2.45 115.51 (96.86–160.60) 2.02
KSG 46.10 (45.15–46.97) 1.77 71.53 (69.28–74.29) 1.25
KTT 32.94 (29.91–35.44) 1.26 59.20 (52.98–70.70) 1.04
VCRU 26.09 (24.25–27.82) 1.00 57.12 (49.87–70.00) 1.00
24000 FH 40.90 (37.83–43.41) 1.98 83.75 (76.70–94.77) 2.63
KSG 34.87 (31.18–37.69) 1.69 63.49 (57.50–74.15) 1.99
KTT 27.96 (22.73–30.86) 1.35 45.75 (38.84–80.74) 1.44
VCRU 20.65 (19.26–21.67) 1.00 31.82 (29.52–36.01) 1.00
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RR of 2.45, 1.77 and 1.26 respectively, while RR against
24000 ITU/L at LT50 for all three localities was 1.98, 1.69 and
1.35 respectively (Table 3).
4. Discussion
Penang Island has experienced increased breeding of Ae.
albopictus which supposedly leads to an increase in the number
of dengue fever cases. There were 878 cases during ﬁrst half of
2014, an increase of 175% compared to 2013 [31]. The present
study indicated that both the larvicide are still effective against
Ae. albopictus larvae as reported previously [17,32]. In
comparison, the standard larvicides used in mosquito control
are still effective against the United States, Thailand and India
population but the monitoring and the need of development of
new tools is still in the ﬁrst priority [33]. Detection of
resistance in larvae often forestall resistance in adult mosquito.
It can also show that the resistance in the larvae can be
expressed and determined in the adult mosquito population.
In Malaysia, temephos has been introduced since the ﬁrst
nationwide dengue fever outbreak in 1973 [34]. The ﬁrst study on
temephos resistance in Ae. aegypti was conducted in Kuala
Lumpur in 1984 and resistance was not detected [35]. A re-
evaluation was carried out in Jinjang, Kuala Lumpur in 1989
and it was found that Ae. aegypti started to develop low resis-
tance towards temephos [36]. However, other study has found
that the larvae of Ae. albopictus were less susceptible to
temephos than in Ae. aegypti [37]. Aedes mosquitoes have a
potential to develop resistance towards temephos under
selection pressure, which is found to be correlated with the
time and ﬁtness costs [38–40].
Temephos is used extensively and intensively in dengue
outbreak areas. This seems to enhance the development of
resistance in the ﬁeld strains. The FH and KSG areas have been
treated repeatedly with operational dose of temephos. Despite
this, Ae. albopictus larvae are still considered susceptible to
temephos with complete mortality in 24 h as shown in our study.
In this study, FH strain, has shown the possibility to develop
faster resistance towards temephos in the future as the RR50 was
the highest among the strains. Similar ﬁndings were reported by
Chen et al. [17]. There is no failure in control activity (100%
mortality in 24 h) in Argentina, but the lethal concentration
and RR values show incipient resistance. It is therefore crucial
to continuously monitor the nationwide temephos resistance
status of Ae. albopictus prior to emergence of high level of
resistance [41].In the current study, Ae. albopictus was susceptible to Vec-
toBac® WG in all concentrations tested. In Penang, Bti has been
used to control dengue vectors since 2003 and such use was
intensiﬁed in 2010. It was used as an alternative larvicide other
than temephos. In Malaysia, as in other parts, there is no report
of resistance among Aedes mosquitoes against Bti. Bti is applied
in the ﬁeld to supplement temephos in order to optimize the
efﬁciency of the larviciding program. This is similar with the
ﬁnding in Lahore, Pakistan, which reported the exposure against
Bti causing RR of 1.97 and 2.22 [25]. No cross-resistance
between Bti and temephos has been reported so far [4].
However, low resistance to Bti has been reported from other
countries [42].
Resistance against Bti was reported due to reduction of the
toxin binding to epithelial lining in the insect gut or the
enhancement of the digestion process of Bti by the gut protease
[25,43]. The frequency of gene resistance may be changed if they
are occasionally exposed or routinely exposed to the insecticide
which brings an advantage to the resistance gene. Other study
also suggested that resistance also occurred from the standing
genetic variation in the affected areas [44]. The ﬂow of the low
genetic variation from treated areas can cause Bti resistance in
other population [45]. The resistance against Bti has also been
found in the laboratory [43,44]. Development of resistance to
Bti is related to the mosquito habitat types which is an
important factor in determining the effectiveness of Bti.
An attempt has been made to evaluate the effectiveness of
temephos and Bti against mosquito larvae. The monitoring of
resistance status must be initiated and fully documented. The
vector control programme will not succeed without any extra
resistance status information, which becomes one of the limi-
tation in vector control activities. This study provided a baseline
reference for the future monitoring on the resistance status of
Ae. albopictus in FH, KSG and KTT. It is very important to
monitor the development of resistance in dengue outbreak
areas. The occurrence of resistance should be mapped out
carefully. However, we preferred source reduction as one of the
most effective strategies. Besides, this method is more direct
and simple to reduce the mosquito population for a long-term
activity. The application of temephos and VectoBac® WG in
vector control management in FH, KSG and KTT is still rele-
vant and serves as an effective tool to control Aedes
populations.
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